Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate Tablet
Product Images NDC 0527-0761

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 0527-0761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 1)

This appears to be an information sheet on a medication called Eodytole. It contains details about the dosage, composition, and storage temperature of the medication. The medication guide must be dispensed to each patient along with the medication. The text also mentions a website for obtaining more information on the medication.*

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 2)

This appears to be the description for a medication called "Mixed Salts of a Single-Entity Amphetamine Product", including various doses of amphetamines and sulfates. It also includes information about storage, dosage, and warnings about keeping the medication out of reach of children. There is a reference to a medication guide that should be provided separately for each patient.*

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 3)

This is a medication guide for a package of pills or tablets that contain various amounts of dexoamphetamine, dectoompheiine st USP, and amphetominesulfte UP. The usual dosage, storage instructions, and the recommended location of where to get more information are provided. The medication is intended to be used by patients and it is advisable to keep it out of reach of children.*

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 4)

This text appears to be a description of a medication called "Amphetamine Sulfate Tablets" produced by Lomett Company, Inc. The tablets contain several ingredients such as Dextroamphetamine Sulfate, Amphetamine Aspartate, and Succharate, and are intended for oral use. The usual dosage is not mentioned but a medication guide is available. It is not clear what medical condition this medication is meant to treat.*

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 5)

This appears to be the product description for a medication containing a combination of dextroamphetamine, amphetamine asparate, and amphetamine sulfate. The usual dosage is not mentioned. The medication needs to be stored in a controlled room temperature at 20-25°C. The medication comes in a sealed, opaque container with a desiccant. The medication guide is provided separately to each patient. The medication is manufactured by Lannett Company and comes in a pack of 100 tablets.*

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 6)

This is a medication label containing information about Dextroamphetamine and Amphetamine tablets used to treat ADHD. It mentions the dosage, storage instructions, and provides a unique identification number. A separate medication guide is provided for each patient to ensure the safe and effective use of the medication.*

FDA Label Image

Label (Dextroamphetamine Saccharate Amphetamine Aspartate 7)

This text contains information about medication dosage for a combination of amphetamine salts including dextroamphetamine sulfate, amphetamine aspartate, and dextroamphetamine saccharate. It provides specific dosages of each salt and gives a warning to keep the medication out of reach of children. The text also provides a reference to a website with more information about dosages.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.